Otsuka Partners With Medibio

Otsuka has recently partnered with Medibio to use Medibio’s system to assess the effectiveness of its top product. Otsuka is known for making the antipsychotic drug Abilify, and Medibio is an Australian digital health company.

Medibio uses wearables to derive data about heart rate, motion, and sleep to create objective bio-markers for mental illness. The objective data can help companies get a better idea of how much of an effect the treatment has. Medibio will analyze an existing set of data from Otsuka to assess the effectiveness of the product.

Medibio is a mental health technology company that . . .